Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Worminfectie beschermt tegen type 2 diabetes
apr 2019 | Diabetes, Parasitaire infecties